Rybelsus vs Ozempic: What’s the Difference?

The oral semaglutide Rybelsus by Novo Nordisk is being renamed as “Ozempic tablets”¹ in several markets from 2026⁶. However, it is still sold and prescribed as Rybelsus in India⁷. This is just a change in the branding, not a new medicine; the molecule is the same semaglutide in both medicines.

In India, both Rybelsus and Ozempic are approved for the treatment of type 2 diabetes. They contain the same active ingredient, semaglutide, but come in different forms: Rybelsus is taken as a tablet, while Ozempic is given as a once-weekly injection.

Semaglutide is a GLP-1 receptor agonist. It works by helping the pancreas release insulin when blood sugar is high, reducing glucagon release, slowing stomach emptying, and increasing feelings of fullness. Together, these effects help lower blood sugar in people with type 2 diabetes.²

Semaglutide can also reduce appetite and body weight, which is why its role in weight management is often discussed. However, in India, neither Rybelsus nor Ozempic is approved specifically for weight management. Using either medicine for weight loss would therefore be an off-label use and should only be considered on a doctor’s advice.

Although a different, higher-dose injectable brand of semaglutide is approved for chronic weight management, called Wegovy. If you are looking for weight management options, discuss with your doctor and check the Wegovy hub. In December 2025, the World Health Organisation recognised obesity as a chronic disease and recommended GLP-1 therapies for adults with obesity as part of an approach including a balanced diet and regular physical activity, under medical guidance.³ However, the exact medicine, brand and dosing is a clinical decision.

Since the active molecule and the indication of both medicines are the same, the choice of which one to use depends on the form, routine and cost, which are discussed further on this page.

The biggest practical difference between Rybelsus and Ozempic is how you take them. Rybelsus is a daily tablet, while Ozempic is a once-weekly injection.

Because it is a tablet, Rybelsus may be preferable if you want to avoid injections. However, it needs to be taken in a specific way for your body to absorb enough of the medicine.⁴

An improper routine, too much water consumption or eating food before the advised 30 minutes might lead to a decrease in absorption. If your mornings are unpredictable, keeping that daily discipline may be harder than it sounds.

It is given as a weekly injection under the skin. Due to this, a proper daily routine and no food-timing rules need to be followed. You can take it on the same day each week, with or without food, at any time of day. However, since this is an injection (a short, fine needle on a pre-filled pen), some people would prefer to avoid it, and it needs cold-chain storage.⁵ For people who find it difficult to follow a strict daily tablet routine, a weekly injection can be beneficial.

Both medicines work similarly and we certainly don’t say that one has better efficacy than the other; however, their forms and doses differ. The choice may be based on what suits your routine or what your doctor suggests depending on some individual factors.

Note: PharmEasy dispenses only 100% genuine, cold-chain-shipped medicines from licensed pharmacies. Counterfeit GLP-1 pens have been reported in India (2026), so buy only against a prescription from a licensed pharmacy and check the pack.

The side effects of both medicines are mostly related to digestive issues for most individuals, especially in the first weeks and after each dose increase. The commonly reported side effects include nausea, diarrhoea, vomiting, constipation and indigestion^4,5. They often become milder as the body gets used to it; that is why doctors start with low doses and gradually increase later. Rybelsus is mostly given from 3 mg to 7 mg to 14 mg, and Ozempic from 0.25 mg upward^4,5. Since both contain the same molecule, the side-effects caused by them are mostly similar, and in practice whether any difference is observed depends on the individual and the dose.

Hypoglycaemia or low blood sugar might result if any of these medicines is combined with insulin or a sulfonylurea. Also, both of these can be associated with more serious problems such as pancreatitis or gallbladder issues, although rarely¹.

If you have a personal or family history of medullary thyroid carcinoma or MEN 2 syndrome, neither of them should be used. Medical supervision is mandatory for using both these medications. For the management of side effects or related concerns, it is best to consult your doctor.

If you are confused about which would suit you, consult a doctor. A doctor can guide you best on whether a GLP-1 medicine suits your health, and the right choice for you. He/She will also issue a prescription for use if needed, and if you already have one, you can view Rybelsus or Ozempic on PharmEasy.